Skip to main content
Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
21.68
+1.98 (10.05%)
At close: Dec 5, 2025, 4:00 PM EST
21.99
+0.31 (1.43%)
After-hours: Dec 5, 2025, 7:46 PM EST

Oculis Holding AG Revenue

Oculis Holding AG had revenue of 243.00K CHF in the quarter ending September 30, 2025, with 12.50% growth. This brings the company's revenue in the last twelve months to 791.00K, down -8.87% year-over-year. In the year 2024, Oculis Holding AG had annual revenue of 686.00K, down -22.31%.

Revenue (ttm)
791.00K CHF
Revenue Growth
-8.87%
P/S Ratio
1,263.36
Revenue / Employee
16,143 CHF
Employees
49
Market Cap
1.25B USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024686.00K-197.00K-22.31%
Dec 31, 2023883.00K-29.00K-3.18%
Dec 31, 2022912.00K-48.00K-5.00%
Dec 31, 2021960.00K-33.00K-3.32%
Dec 31, 2020993.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

OCS News

More News